Showing results (111-120 of 2,064) with videos related to

Sort By:
Pageof 207
Kidney & Blood Pressure Research|July 23, 2013
HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activityHae Jin Kee, Eun Hui Bae, Sangha Park, et al.
Kidney & Blood Pressure Research|January 12, 2013
Investigating the effect of CoCl2 administration on diabetic nephropathy and associated aortic dysfunctionA B Deshmukh, J K Patel, A R Prajapati, et al.
Kidney & Blood Pressure Research|December 14, 2012
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?Leszek Tylicki, Sławomir Lizakowski, Przemysław Rutkowski, et al.
Kidney & Blood Pressure Research|April 4, 2013
Cardiovascular risk and mineral bone disorder in patients with chronic kidney diseaseHagen Staude, Susann Jeske, Karin Schmitz, et al.
Kidney & Blood Pressure Research|April 5, 2013
Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidismJoerg Latus, Renate Lehmann, Meike Roesel, et al.
Kidney & Blood Pressure Research|April 19, 2013
Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjectsSul ra Lee, Joo Young Moon, Sang Ho Lee, et al.
Kidney & Blood Pressure Research|April 19, 2013
The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapyRefmir Tadzic, Martina Mihalj, Aleksandar Vcev, et al.
Kidney & Blood Pressure Research|June 6, 2013
Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect ∼ a pilot study∼Hidekazu Moriya, Shuzo Kobayashi, Takayasu Ohtake, et al.
Kidney & Blood Pressure Research|May 23, 2012
What is the quality of pre-dialysis healthcare in the Czech Republic?Jana Smržová, Tomáš Urbánek, Martin Dvořák, et al.
Kidney & Blood Pressure Research|June 13, 2012
Exenatide reduces urinary transforming growth factor-β1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuriaHong Zhang, Xiangcheng Zhang, Changjun Hu, et al.
Pageof 207